Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$499.74 -9.01 (-1.77%)
At close: Oct 16, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Finished Goods (2011 - 2012)

Updated

Vertex Pharmaceuticals' Finished Goods was $23.32 million in Q3 2012, up 94.2% from $12.01 million a year earlier but down 0.8% from the prior quarter.

Analysis

Vertex Pharmaceuticals (VRTX) Finished Goods (2011 - 2012) Analysis & Trends

At the end of FY2011, Finished Goods at Vertex Pharmaceuticals came in at $33.21 million.

  • Quarterly Finished Goods has moved between $12.01 million (Q3 2011) and $33.21 million (Q4 2011) over five years.
  • Per Business Quant data, VRTX's Finished Goods in the three quarters before Q3 2012 was $23.51 million (Q2 2012), $26.35 million (Q1 2012) and $33.21 million (Q4 2011).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 23.32 Mn
Jun 30, 2012 23.51 Mn
Mar 31, 2012 26.35 Mn
Dec 31, 2011 33.21 Mn
Sep 30, 2011 12.01 Mn
Jun 30, 2011 1.58 Mn
API Access

Vertex Pharmaceuticals Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=VRTX&period=max&api_key=YOUR_API_KEY